BACKGROUND: Delirium has been hypothesized to be a central nervous system response to systemic inflammation during a state of blood-brain barrier compromise. The purpose of this study was to compare postoperative changes in groups of inflammatory markers in persons who developed delirium following cardiac surgery and matched controls without delirium. METHODS: Serum samples were drawn from 42 patients undergoing cardiac surgery preoperatively and postoperatively at 6 hours and postoperative day 4. The serum concentrations of 28 inflammatory markers were determined with a microsphere flow cytometer. A priori, inflammatory markers were assigned to five classes of cytokines. A class z score was calculated by averaging the standardized, normalized levels of the markers in each class. Beginning on postoperative day 2, patients underwent a daily delirium assessment. RESULTS: Twelve patients with delirium were matched by surgical duration, age, and baseline cognition to 12 patients without delirium. At the 6-hour time point, patients who went on to develop delirium had higher increases of chemokines compared to matched controls (class z score 0.3 +/- 1.0, p <.05). Among the five classes of cytokines, there were no other significant differences between patients with or without delirium at either the 6 hour or postoperative day 4 assessments. CONCLUSION: After cardiac surgery, chemokine levels were elevated in patients who developed delirium in the early postoperative period. Because chemokines are capable of disrupting blood-brain barrier integrity in vitro, future studies are needed to define the relationship of these inflammatory mediators to delirium pathogenesis.
BACKGROUND: Delirium has been hypothesized to be a central nervous system response to systemic inflammation during a state of blood-brain barrier compromise. The purpose of this study was to compare postoperative changes in groups of inflammatory markers in persons who developed delirium following cardiac surgery and matched controls without delirium. METHODS: Serum samples were drawn from 42 patients undergoing cardiac surgery preoperatively and postoperatively at 6 hours and postoperative day 4. The serum concentrations of 28 inflammatory markers were determined with a microsphere flow cytometer. A priori, inflammatory markers were assigned to five classes of cytokines. A class z score was calculated by averaging the standardized, normalized levels of the markers in each class. Beginning on postoperative day 2, patients underwent a daily delirium assessment. RESULTS: Twelve patients with delirium were matched by surgical duration, age, and baseline cognition to 12 patients without delirium. At the 6-hour time point, patients who went on to develop delirium had higher increases of chemokines compared to matched controls (class z score 0.3 +/- 1.0, p <.05). Among the five classes of cytokines, there were no other significant differences between patients with or without delirium at either the 6 hour or postoperative day 4 assessments. CONCLUSION: After cardiac surgery, chemokine levels were elevated in patients who developed delirium in the early postoperative period. Because chemokines are capable of disrupting blood-brain barrier integrity in vitro, future studies are needed to define the relationship of these inflammatory mediators to delirium pathogenesis.
Authors: Sameena S Khan; Meghan S Smith; Debra Reda; Anthony F Suffredini; J Philip McCoy Journal: Cytometry B Clin Cytom Date: 2004-09 Impact factor: 3.058
Authors: Oliver B Dimitrijevic; Svetlana M Stamatovic; Richard F Keep; Anuska V Andjelkovic Journal: J Cereb Blood Flow Metab Date: 2006-06 Impact factor: 6.200
Authors: Basel Ramlawi; James L Rudolph; Shigetoshi Mieno; Jun Feng; Munir Boodhwani; Kamal Khabbaz; Sue E Levkoff; Edward R Marcantonio; Cesario Bianchi; Frank W Sellke Journal: Surgery Date: 2006-08 Impact factor: 3.982
Authors: Elisabeth Tarkowski; Ann Marie Liljeroth; Lennart Minthon; Andrzej Tarkowski; Anders Wallin; Kaj Blennow Journal: Brain Res Bull Date: 2003-08-15 Impact factor: 4.077
Authors: Konstanze Plaschke; Philipp Fichtenkamm; Christoph Schramm; Steffen Hauth; Eike Martin; Markus Verch; Matthias Karck; Jürgen Kopitz Journal: Intensive Care Med Date: 2010-08-06 Impact factor: 17.440
Authors: Sarinnapha M Vasunilashorn; Long Ngo; Sharon K Inouye; Towia A Libermann; Richard N Jones; David C Alsop; Jamey Guess; Sandra Jastrzebski; Janet E McElhaney; George A Kuchel; Edward R Marcantonio Journal: J Gerontol A Biol Sci Med Sci Date: 2015-07-27 Impact factor: 6.053
Authors: Jason B O'Neal; Frederic T Billings; Xulei Liu; Matthew S Shotwell; Yafen Liang; Ashish S Shah; Jesse M Ehrenfeld; Jonathan P Wanderer; Andrew D Shaw Journal: Can J Anaesth Date: 2017-07-17 Impact factor: 5.063
Authors: Sheila A Alexander; Dianxu Ren; Scott R Gunn; Patrick M Kochanek; Judith Tate; Milos Ikonomovic; Yvette P Conley Journal: Am J Crit Care Date: 2014-01 Impact factor: 2.228
Authors: Ashraf A Sabe; Rahul S Dalal; Louis M Chu; Nassrene Y Elmadhun; Basel Ramlawi; Cesario Bianchi; Frank W Sellke Journal: J Thorac Cardiovasc Surg Date: 2014-10-14 Impact factor: 5.209
Authors: Meredith Hay; Robin Polt; Michael L Heien; Todd W Vanderah; Tally M Largent-Milnes; Kathleen Rodgers; Torsten Falk; Mitchell J Bartlett; Kristian P Doyle; John P Konhilas Journal: J Pharmacol Exp Ther Date: 2019-02-01 Impact factor: 4.030